India's Dr. Lal Pathlabs gains on higher Q3 profit

Dr. Lal PathLabs

30/01/2025 09:19

** Shares of Dr. Lal Pathlabs  DLPA.NS  rise 3.5% to 2,86.1
rupees
    ** The diagnostics firm posted a 19% rise in Q3 consol net
profit to 967 mln rupees ($11.2 mln); rev from ops up 11% Y/Y
    ** Profit aided by strong volume growth through expansion in
core markets and in newer regions of west and south
    ** More than 812,000 shares change hands, 3.3x its 30-day
avg
    ** 20 analysts covering the stock on avg have a "hold"
rating; median PT is 3,310 rupees - LSEG data
    ** Stock gained 16% in 2024
     


($1 = 86.5700 Indian rupees)

 (Reporting by Ashna Teresa Britto in Bengaluru)
 ((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))